Plasma Levels of Brain Natriuretic Peptide Predict Postoperative Atrial Fibrillation in Patients Undergoing Heart Surgery

심장 수술 후 심방세동 발생의 예측 인자로서 혈중 BNP 농도

  • Kwon, Jin-Tae (Department of Thoracic and Cardiovascular Surgery, College of Medicine, Yeungnam University) ;
  • Jung, Tae-Eun (Department of Thoracic and Cardiovascular Surgery, College of Medicine, Yeungnam University) ;
  • Lee, Jang-Hoon (Department of Thoracic and Cardiovascular Surgery, College of Medicine, Yeungnam University) ;
  • Lee, Dong-Hyup (Department of Thoracic and Cardiovascular Surgery, College of Medicine, Yeungnam University)
  • 권진태 (영남대학교 의과대학 흉부외과학교실) ;
  • 정태은 (영남대학교 의과대학 흉부외과학교실) ;
  • 이장훈 (영남대학교 의과대학 흉부외과학교실) ;
  • 이동협 (영남대학교 의과대학 흉부외과학교실)
  • Published : 2007.06.05

Abstract

Background: The brain natriuretic peptide (BNP) level has been reported in some studies to be associated with the occurrence of atrial fbrillation (AF). The aim of this study is to evaluate the potential usefulness of the BNP level as a predictor of the occurrence of postoperative (postop) AF and to assess the relationship of the BNP level with the onset of AF and the restoration of sinus rhythm. Material and Method: From January 1, 2005 to February 28, 2006, 82 patients without a history of atrial arrhythmia that had undergone cardiac surgery were enrolled in the study. Blood samples for plasma BNP were drawn daily for all these patients from the preoperative (preop) day to the 7th postop day. The patient records were reviewed and postop EKGs were checked daily for AF until the time of discharge. Result: Patients were divided into two groups based on development of postop AF. Postoperative AF developed in 26 patients (31.7%). There was no significant statistical difference in age, sex distribution, preop left ventricle ejection fraction, hypertension, left ventricular hypertrophy, or the use of beta blockers between the non-postop AF and postop AF group. More patients in the AF group had undergone valve surgery (39.3% versus 76.9%, p=0.002). The preop left atrium size was significantly larger in the AF patients ($43.8{\pm}10.3 mm$ versus $49.8{\pm}11.5 mm$, p=0.029). The preop plasma BNP levels were higher in the postop AF patients ($144.1{\pm}20.8 pg/mL$ versus $267.5{\pm}68 pg/mL$, p=0.034). In the postop AF group, the plasma BNP level was the highest on the 3rd postop day. Postop AF developed in most patients by the 3rd postop day; restored sinus rhythm developed by the 7th postop day. Conclusion: Elevated plasma BNP levels may lead to the occurrence of postop AF in patients undergoing cardiac surgery. Patients who have a high risk of postop AF should be considered for aggressive prophylactic antiarrhythmic therapy.

배경: 혈중 BNP 농도가 심방세동 발생과 관련 있다는 여러 보고가 있다. 본 연구의 목적은 혈중 BNP 농도가 술 후 심방세동의 발생에 유용한 예견인자인지 알아보고 술 후 BNP 수치의 변화와 심방세동 발생시기 및 심방세동이 정상 동율동으로 돌아오는 시기를 알아보고자 하였다. 대상 및 방법: 2005년 1월 1일부터 2006년 2월 28일까지 개심술을 받은 환자 중 심방부정맥의 병력이 없는 82명의 환자를 대상으로 하였다. 혈중 BNP 농도 측정을 위한 혈액 채취는 술 전부터 술 후 7일째까지 매일 하였다. 술 후 심전도 검사는 퇴원 전까지 매일 시행하였다. 결과: 환자는 술 후 심방세동 발생 유무에 따라 두 군으로 나누었다. 술 후 심방세동은 26명(31.7%)에서 발생하였다. 심방세동 없는 군과 발생군 사이에 나이, 성별, 술 전 좌심실 구혈률, 고혈압, 좌심실 비대, 베타 차단제 복용 유무에 대해 통계학적인 의미 있는 차이는 없었다. 판막 수술을 받은 환자에서 술 후 심방세동의 발생이 많았다(39.3% vs 76.9%, p=0.002). 술 전 좌심방 크기는 심방세동 발생군에서 의미 있게 컸다($43.8{\pm}10.3 m$ vs $49.8{\pm}11.5 mm$, p=0.029). 술 전 혈중 BNP 농도는 심방세동 발생군에서 의미 있게 높았다($144.1{\pm}20.8 pg/mL$ vs $267.5{\pm}68 pg/mL$, p=0.034). 심방세동군에서 술 후 BNP 수치는 술 후 3일째 가장 높았고 심방세동 발생은 술 후 3일 이내가 가장 많이 발생하였고 술 후 일주일 이내 대부분 정상 동율동으로 돌아왔다. 결론: 혈중 BNP 농도의 증가는 심장 수술 후 심방세동 발생을 예측하는 데 유용한 인자이다. 심방세동 발생의 위험인자가 있는 경우 술 후 적극적으로 예방적 항부정맥제 사용을 고려해야 한다.

Keywords

References

  1. Patti G, Chello M, Candura D, et al. Randomized trial Atorvastatin for reduction of postoperative atrial fibrillation in patient undergoing cardiac surgery. Results of the ARMYDA-3 (Atorvastatin for reduction of myocardial dysrhythmia after cardiac surgery) study. Circulation 2006;114: 1455-61 https://doi.org/10.1161/CIRCULATIONAHA.106.635854
  2. Wazni OM, Martin DO, Marrouche NF, et al. Plasma B-type natriuretic peptide levels predict postoperative atrial fibrillation in patients undergoing cardiac surgery. Circulation 2004;110:124-7 https://doi.org/10.1161/01.CIR.0000134481.24511.BC
  3. Albage A, Kenneback G, Linden JVd, Berglund H. Improved neurohormonal markers of ventricular function after restoring sinus rhythm by the Maze procedure. Ann Thorac Surg 2003;75:790-5 https://doi.org/10.1016/S0003-4975(02)04543-5
  4. Jahangiri M, Weir G, Mandal K, Savelieva I, Camm J. Current strategies in the management of atrial fibrillation. Ann Thorac Surg 2006;82:357-64 https://doi.org/10.1016/j.athoracsur.2005.11.035
  5. Inoue SI, Murakami Y, Sano K, Katoh H, Shimada T. Atrium as a source of brain natriuretic polypeptide in patients with atrial fibrillation. J Card Fail 2000;6:92-6 https://doi.org/10.1016/S1071-9164(00)90010-1
  6. Kang DH, Kim MJ, Kang SJ, et al. Role of B-type natriuretic peptide in diagnosis and follow-up of diastolic heart failure. Korean Circ J 2006;36:359-65 https://doi.org/10.4070/kcj.2006.36.5.359
  7. Creswell LL, Schuessler RB, Rosenbloom M, Cox JL. Hazards of postoperative atrial arrhythmias. Ann Thorac Surg 1993;56:539-49 https://doi.org/10.1016/0003-4975(93)90894-N
  8. Leitch JW, Thomson D, Baird DK, Harris PJ. The importance of age as a predictor of atrial fibrillation and flutter after coronary artery bypass grafting. J Thorac Cardiovasc Surg 1990;100:338-42
  9. Aranki SF, Shaw DP, Adams DH, et al. Predictors of atrial fibrillation after coronary artery surgery current trends and impact on hospital resources. Circulation 1996;94:390-7 https://doi.org/10.1161/01.CIR.94.3.390
  10. Borzak S, Tisdale JE, Amin NB, et al. Atrial fibrillation after bypass surgery: does the arrhythmia or the characteristics of the patients prolong hospital stay? Chest 1998; 113:1489-91 https://doi.org/10.1378/chest.113.6.1489
  11. Kim MH, Deeb GM, Morady F, et al. Effect of postoperative atrial fibrillation on length of stay after cardiac surgery (The postoperative atrial fibrillation in cardiac surgery study [PACS2]). Am J Cardiol 2001;87: 881-5 https://doi.org/10.1016/S0002-9149(01)01448-5
  12. Naoko M, Takayoshi T, Keiko M, Masahiko K. Plasma cardiac natriuretic peptides as biochemical makers of recurrence of atrial fibrillation in patients with mild congestive heart failure. Jpn Circ J 2000;64:765-71 https://doi.org/10.1253/jcj.64.765
  13. Shimizu H, Masuta K, Aono K, et al. Molecular forms of human brain natriuretic peptide in plasma. Clin Chim Acta 2002;316:129-35 https://doi.org/10.1016/S0009-8981(01)00745-8
  14. Kohno M, Hario T, Yokokawa K, et al. Brain natriuretic peptide as a cardiac hormone in essential hypertension. Am J Med 1992;92:29-34 https://doi.org/10.1016/0002-9343(92)90011-Y
  15. Mathew JP, Parks R, Savino JS, et al. Atrial fibrillation following coronary artery bypass graft surgery predictors, outcomes, and resoruce utillization. JAMA 1996;276:300-6 https://doi.org/10.1001/jama.276.24.1996
  16. Horie H, Tsutamoto T, Minai K, Hayashi M, Kito O, Kinoshita M. Brain natriuretic peptide predicts chronic atrial fibrillation after ventricular pacing in patients with sick sinus syndrome. Jpn Circ J 2000;64:965-70 https://doi.org/10.1253/jcj.64.965